|
|style= color:white; font-size:100%" align=center bgcolor=#37c8ab|'''Forbes ranking 2017'''
|style= color:white; font-size:100%" align=center bgcolor=#37c8ab|'''Company'''
|colspan=3 style= color:white; font-size:100%" align=center bgcolor=#37c8ab|'''Secteur'''
|style= color:white; font-size:100%" align=center bgcolor=#37c8ab|'''Poids'''
|style= color:white; font-size:100%" align=center bgcolor=#37c8ab|'''Logo'''
|style= color:white; font-size:100%" align=center bgcolor=#37c8ab|'''Site Web'''
|style= color:white; font-size:100%" align=center bgcolor=#37c8ab|'''Site Web'''
|-
| 1830#118 || [[Gilead Sciences]] || UMSA {{USA}}|| Estatal$32.2 || 138.1 51.8 32.2 18.1 || 182 ||51.8 - || 2 || 138.1 || [http://www.umsagilead.bocom/ UMSA]
|-
| 1994#131 || [[Amgen]] || UCB{{USA}} || Privada || 122$21.4 71.6B 21.4|| $6.9 || 308B || -71.6 || 3 || 122.4 || [http://www.ucb.eduamgen.bocom/ UCB]
|-
| -#384 || [[Biogen Idec]] || UNICEN{{USA}} || Privada || 61$10.9 19.5B 10.9|| 3.5 || 489 || -19.5 || 5 || 61.9 || [httphttps://www.unicen.edubiogen.bocom/ UNICEN]
|-
| -#397 || [[Celgene]] || UPV{{USA}} || Privada$9.1 B || 86.4 27.1 9.1 $1.6 || 757 ||27.1 - || 8 || 86.4 || [http://www.univallecelgene.educom/ UPV]
|-
| -#818 || [[CSL]] || UPB{{AUS}} || Privada$5.8 B || 37 7.5 5.8 $1.4 B || 8227.5 || - || 9 || 37 || [http://www.upbcsl.com.eduau/ UPB]
|-
| 1950#1070 || [[Regeneron Pharmaceuticals]] || EMI{{USA}} || Estatal || 42.4 5.6 4.1 636M || 1636 103 || -5.6 || 1342.4 || [https://www.regeneron.com/ ] || [httphttps://www.emi.edutwitter.bocom/regeneron EMI]
|-
| -#1207 || [[Grifols]] || UDABOL{{ESP}} || Privada || 13.6 10.4 $4.4 590M || 1$590 170 || -10.4 || 15 || 13.6 || [http://www.udabol.edugilead.bocom/ UDABOL]
|-
| -#1330 || [[Illumina]] || {{USA}} || Privada || 21.1 3.7 $2.2 462M || 1$462 174 || -3.7 || 16 || 21.1 || [httphttps://www.usalesianaillumina.edu.bocom// Salesiana] https://twitter.com/illumina
|-
| -#1356 || [[Alexion Pharmaceuticals]] || {{USA}} || Privada || 35.8 13.1 2.5 144M || 1144 333 || -$13.1 B || 18 ||35.8 || [http://www.nuralexion.educom/ NUR]
|-
| -#1492 || [[Novozymes]] || {{DAN}} || Privada || 14.4 2.7 $2.1 423M B || 1423 333 || -2.7 || 18 ||14.4 || [http://www.nurnovozymes.educom/en NUR]
|-
| -#1725 || [[Vertex Pharmaceuticals]] || {{USA}} || Privada || 21.4 2.5 $1 -558M || 1$-558 499 || -$2.5 || 20 || 21.4 || [httphttps://www.loyolavrtx.edu.bocom/ Loyola] https://twitter.com/VertexPharma
|-
| -#1865 || [[Shanghai RAAS Blood Products]] || UASB{{CHN}} || Estatal$319 || 15.8 1.8 319M 230M $230 || $1.8 506 || - || 21B || 15.8 || [http://www.uasb.edugilead.bocom/ UASB]
|-
| -#1894 || [[BioMarin Pharmaceutical]] || {{USA}} || Privada$877 || 15.2 3.7 877M $-172M || 1172 499 || -$3.7 || 20B || 15.2 || [http://www.loyola.edubiomarin.bocom/ Loyola]
|-
| -#1968 || [[United Therapeutics]] || UASB{{USA}} || Estatal || 5.4 2.2 $1.5 652M || 1$652 506 || - ||$2.2 21B || 5.4 || [http://www.uasbunither.edu.bocom/index.html UASB]
|}
| 